Controversies about extended-spectrum and AmpC beta-lactamases.
about
Beta-Lactamase Producing Escherichia coli Isolates in Imported and Locally Produced Chicken Meat from GhanaNew disturbing trend in antimicrobial resistance of gram-negative pathogensMolecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitalsExtended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial OriginExtended-spectrum-beta-lactamase, AmpC, and Carbapenemase issuesPrevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil.Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, BrazilAntibiotic susceptibility pattern in urinary isolates of gram negative bacilli with special reference to AmpC β-lactamase in a tertiary care hospital.Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan.Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan.Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae.Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal.Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in IndiaEscherichia coli producing CTX-M-2 beta-lactamase in cattle, Japan.Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.Genotypic and Phenotypic Detection of AmpC β-lactamases in Enterobacter spp. Isolated from a Teaching Hospital in Malaysia.Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical CentersMultiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae.Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.Detection of Extended Spectrum B-Lactamases in Urinary Isolates of Klebsiella pneumoniae in Relation to Bla, Bla and Bla Gene Carriage.Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.Antibiotic Resistance, RAPD- PCR Typing of Multiple Drug Resistant Strains of Escherichia Coli From Urinary Tract Infection (UTI)Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapyOccurrence and characteristics of extended spectrum beta-lactamases-producing Enterobacteriaceae from foods of animal origin.Extended-spectrum beta-lactamase-producing bacteria isolated from hematologic patients in Manaus, State of Amazonas, BrazilFrequency of plasmid-mediated AmpC in Enterobacteriaceae isolated in a Brazilian Teaching Hospital.AmpC beta-lactamases.The use of carbapenems in the treatment of serious infections.Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.Gene and Protein Network Analysis of AmpC β Lactamase.Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolatesBacteremia in Early Infancy: Etiology and Management.Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli.Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.Detection of ESBL- and AmpC-producing E. coli isolates from urinary tract infections.Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
P2860
Q28550186-31A08163-46DB-4F3C-9376-66DF1624D30DQ33422956-52AD4417-427B-4480-B9DF-75B062FA8F14Q33554703-59AD632A-EB8D-4254-9203-9D3014CF8F1CQ33736461-40FC7F8B-7C69-4C69-A1C1-D89778DC70A5Q33769534-436893D9-5809-4936-AF61-C5449C6BD57AQ33949179-67DEB340-395A-4097-B40D-E36390D0D243Q33960971-218959AA-51D5-4AB9-AE5C-9D62E68556CFQ34106989-E626730D-A643-4BC3-A560-071CBEDAFCEBQ34195633-88C9B78A-058F-4AC1-A59D-697FD89C2DA6Q34219120-1B97F4C8-4D37-43ED-9B89-1318CDE3BE56Q34336140-D981E605-2318-4648-B973-EED06791E07EQ34991064-7B44B1E5-CE6E-40AD-8B1A-A3F0E140773FQ35073335-ADB351E5-46A1-43FC-8B90-FC9F55EE29BEQ35139767-F416E8DD-27EE-4017-9EDB-66F05A76320EQ35552314-5A6AD08A-4DE8-4DA1-A404-AEF053DA4E90Q35559648-4E36EC21-DCE5-401E-92B3-E00C479CCE48Q35838632-96D5F5CC-16C9-4FAF-9A6D-A476213D559FQ35879241-4BF40B08-66D9-4836-91CE-B38353944DCAQ35917401-5FC1B182-CDC7-4437-9171-6244B20F1507Q35952543-826AA4C9-DE87-488C-B245-DA888D899DD1Q35993279-3D43475F-551F-483F-B80F-F561F55C1D3CQ36095002-0D334F88-ECB3-4AD8-B570-68063C8B900AQ36139832-E72C4172-B602-458F-AB57-9CA1072863DAQ36348949-645B9BB0-A5C7-43E8-8BFC-333F0D9D1B0EQ36424079-9429C789-8060-482B-A879-5FC8A5732798Q36830996-8805BFBF-FEDC-4869-9E9F-DAC8733DE46CQ36870786-83C8D96D-9E05-4D87-828F-A580D067421DQ36921676-41C2502D-E457-4E48-A58B-911B4AA589F7Q37159830-A4082ED2-FB0A-4084-AB49-EFE08AB40D59Q37322838-6E6535FE-5457-4049-8B8F-4416EA94ADD6Q37366249-76099426-FA77-400B-8D3C-C7A5D924CF63Q37555757-32A032B4-5678-4BD8-8153-B714955308DBQ37568924-E919C6C9-E092-4F62-9538-7818049D9F56Q38470588-EE67F6F1-1172-4B43-860E-658D6B92F70CQ38475591-F9F2D391-B106-41B3-BF77-695823D19BC0Q38678086-AEBF1703-D6CD-4886-A525-A212DCE24946Q39022423-1CFA96BD-0DB2-4509-BB61-BFF2FDADA4BEQ39664817-A600B459-7867-4EED-902B-2E523EDB9424Q40895884-2C34FAA6-142F-4BE9-B4E8-5325CBC2C442Q41114363-78B7CA74-CF3E-4674-99D6-1B94276E43D8
P2860
Controversies about extended-spectrum and AmpC beta-lactamases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Controversies about extended-spectrum and AmpC beta-lactamases.
@ast
Controversies about extended-spectrum and AmpC beta-lactamases.
@en
Controversies about extended-spectrum and AmpC beta-lactamases.
@nl
type
label
Controversies about extended-spectrum and AmpC beta-lactamases.
@ast
Controversies about extended-spectrum and AmpC beta-lactamases.
@en
Controversies about extended-spectrum and AmpC beta-lactamases.
@nl
prefLabel
Controversies about extended-spectrum and AmpC beta-lactamases.
@ast
Controversies about extended-spectrum and AmpC beta-lactamases.
@en
Controversies about extended-spectrum and AmpC beta-lactamases.
@nl
P2860
P356
P1476
Controversies about extended-spectrum and AmpC beta-lactamases.
@en
P2093
Thomson KS
P2860
P304
P356
10.3201/EID0702.010238
P577
2001-03-01T00:00:00Z